# Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

> **NCT06246357** · PHASE2 · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 80 (estimated)

## Conditions studied

- Hyperaldosteronism
- Hypercortisolism
- Cushing s Syndrome

## Interventions

- **DRUG:** [68Ga]Ga-PentixaFor

## Key facts

- **NCT ID:** NCT06246357
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-23
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06246357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06246357, "Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06246357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*